Astrea Bioseparations Ltd.
In 1987, a Cambridge University working group spun out under the name Affinity Chromatography Limited. Through the years, the name and owner changed, including time as Prometic Bioseparations before being sold in late 2019 and subsequently rebranding to Astrea Bioseparations. We are a Gamma Biosciences company, focused on helping to bring small and large molecule, and advanced therapies to market with industry leading bioseparation adsorbents and resins. Our team is honored to supply reliable, world class resins for more than 21 FDA and EMA approved manufacturing processes. The global experts in providing products & tools for the complete bioseparation workflow.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Monitoring
- Market Focus:
- Globally (various continents)
- Year Founded:
- 1987
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
- Nereus LentiHERO - Model NL100100 - Multiple Lab-Scale Lentiviral Feedstocks
- Evolve D - Column Packing Services
- Fabsorbent - Model 3904 - F1P HF - Selectively Binds Antibody Light-Chains
- PuraBead RoboColumns - Model 4520-PC3450 - CM and HF - Ion Exchange (IEX) Chromatography Adsorbent
- Astrea Etoxiclear - Model 3250 - Chromatography Adsorbent
About Us
Astrea was the Greek “star-maiden” goddess of justice, innocence, purity, and precision. Taking the name Astrea Bioseparations reflects our own focus on purity, precision, and humanity in all we do. Astrea was represented by the constellation Virgo, which we frequently apply for the striking resemblance to a molecular diagram.
A Commitment to Quality
Astrea Bioseparations is honored to support the biopharmaceutical industry with products and services that help bring life-saving and improving medicines to market. Regardless of process scale, we are ready to build Purity by Design into each process to ensure quality and speed to market.